Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 7:17 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–168 of 1,480 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Commercially Available Clear all

Conditions: Diabetic Foot Ulcer, Ulcer Foot, Diabetic Foot
Interventions: Offloading, Additional (outer) Dressing Application, Mirragen Wound Matrix Dressing, Fibracol Wound Dressing; Other
Lead sponsor: ETS Wound Care, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 5
States / cities: St Louis, Missouri • Youngstown, Ohio • Martinsville, Virginia + 2 more

Conditions: Irritant Contact Dermatitis
Interventions: Skin Testing of Hair cleansing products; Other
Lead sponsor: HealthPartners Institute; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Interstitial Lung Disease, Obstructive Sleep Apnea
Interventions: Continuous positive airway pressure (CPAP) therapy, Nox A1 Recorder; Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 2,021 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 2
States / cities: Boston, Massachusetts • New York, New York

Conditions: Urgent Urinary Incontinence
Interventions: selective bladder denervation using RF energy; Device
Lead sponsor: Hologic, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2030
U.S. locations: 6
States / cities: Wichita, Kansas • Shreveport, Louisiana • Pittsburgh, Pennsylvania + 2 more

Conditions: Cow's Milk Allergy
Interventions: Test extensively hydrolyzed formula, Control extensively hydrolyzed formula; Other
Lead sponsor: Société des Produits Nestlé (SPN); Industry
Eligibility: 2 Months to 4 Years
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 8
States / cities: Little Rock, Arkansas • Mission Viejo, California • St. Petersburg, Florida + 5 more

Conditions: Nephrotic Syndrome in Children, Minimal Change Disease, Focal Segmental Glomerulosclerosis
Interventions: Transcutaneous auricular vagus nerve stimulation, Sham device; Device
Lead sponsor: Northwell Health; Other
Eligibility: 3 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: New Hyde Park, New York • Philadelphia, Pennsylvania

Conditions: Duchenne Muscular Dystrophy
Interventions: Golodirsen 50 MG/1 ML Intravenous Solution [VYONDYS 53]; Drug
Lead sponsor: Rare Disease Research, LLC; Other
Eligibility: 7 Years and older · Male only
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 2
States / cities: Atlanta, Georgia • Pittsburgh, Pennsylvania

Conditions: Prostate Cancer
Interventions: Observation; Other
Lead sponsor: BioProtect; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: Campbell, California • Reno, Nevada

Conditions: Stroke
Interventions: Virtual-reality based dance training; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 90 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Intraocular Lens Replacement
Interventions: OMS302, Placebo; Drug
Lead sponsor: Omeros Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 405 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 16
States / cities: Chandler, Arizona • Glendale, Arizona • Los Angeles, California + 13 more

Conditions: Heart Rate Monitors, Athletes Heart
Interventions: Fitbit Iconic HR and Garmin Vivosmart HR, Fitbit Iconic HR and TomTom Spark 3, Garmin Vivosmart HR and TomTom Spark 3, Fitbit Iconic HR and Apple Watch III, Apple Watch III and Garmin Vivosmart HR, Apple Watch III and TomTom Spark 3; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Cognitive Change, Nutrient Deficiency, Nutritional Anemia, Visual Spatial Processing, Diet, Healthy, Diet; Deficiency, Dietary Deficiency, Dietary B12 Deficiency, Dietary Zinc Deficiency, Dietary Vitamin B12 Deficiency Anemia, Dietary Deficiency of Selenium and Vitamin E
Interventions: 30 day Daily consumption of 1 serving of beef, 30 day Daily consumption of 1 serving of the vegatable protein source; Dietary Supplement
Lead sponsor: Texas A&M University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: College Station, Texas

Conditions: Normal Eyes, Abnormal Eyes
Interventions: Investigational Biometer, IOLMaster 700 Biometer; Device
Lead sponsor: Cylite Pty Ltd; Industry
Eligibility: 22 Years and older
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Woburn, Massachusetts

Conditions: Hydration
Interventions: Berry Propel Fitness Water, Essentia Hydroboost Raspberry Pomegranate, Smart Water; Dietary Supplement
Lead sponsor: University of Memphis; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Non-inflammatory Degenerative Joint Disease, Rhematoid Arthritis, Correction of Functional Deformity, Fracture of the Humeral Head, Traumatic Arthritis, Revision of the Devices if Sufficient Bone Stock Remains
Interventions: Tornier Perform™ Reversed MonoPost; Device
Lead sponsor: Stryker Trauma and Extremities; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 2
States / cities: Rancho Mirage, California • Columbus, Ohio

Conditions: Diabetes Mellitus, Type 2
Interventions: Insulin glargine, 300 U/ml, Insulin glargine, 100 U/ml, Insulin detemir, Background Therapy; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 3,304 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 407
States / cities: Birmingham, Alabama • Gulf Shores, Alabama • Guntersville, Alabama + 304 more

Conditions: Colorectal Cancer, Metastatic
Interventions: Pharmacokinetic 5-FU dose adjustment using OnDose® assay, Standard of care; Other
Lead sponsor: Myriad Genetic Laboratories, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 58
States / cities: Birmingham, Alabama • Corona, California • Fountain Valley, California + 55 more

Conditions: High Intensity Exercise, Normal Cognition, Exercise Intervention
Interventions: Indoor Cycling (IC); Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 65 Years to 80 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Non-small Cell Lung Carcinoma, Urothelial Carcinoma, Gastrointestinal Carcinoma, Non-colon, Upper Aerodigestive Tract Carcinoma
Interventions: Afatinib, Regorafenib, Cabozantinib; Drug
Lead sponsor: SCRI Development Innovations, LLC; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 8
States / cities: Denver, Colorado • Fort Myers, Florida • St. Petersburg, Florida + 5 more

Conditions: Dehydration
Interventions: Exercise Intervention; Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 35 Years · Male only
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Clinical High Risk for Psychosis
Interventions: Targeted Cognitive Training, Computer Games; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 15 Years to 30 Years
Enrollment: 139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Premature Infant
Interventions: High protein supplementation, Standard protein supplementation; Dietary Supplement
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 1 Day to 21 Days
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Chronic Pain, Intractable Pain
Interventions: Commercially available Inceptiv™ neurostimulation systems; Device
Lead sponsor: Medtronic; Industry
Eligibility: 18 Years and older
Enrollment: 970 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2034
U.S. locations: 8
States / cities: Phoenix, Arizona • San Diego, California • Temecula, California + 5 more

Conditions: Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma
Interventions: cemiplimab; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 287 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 51
States / cities: Huntsville, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 44 more

Search by objective public record fields.

Resorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers

Prospective Single Center Randomized Double Blind Controlled Tolerability Trial of Six Hair Cleansing Conditioners

Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD

RF Ablation of the Trigone for the Treatment of UUI

Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula

taVNS for FRNS in Children

An Open-Label Study of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy

Prospective Evaluation of a Commercially Available Hydrogel Spacer

Alternative Therapies for Improving Physical Function in Individuals With Stroke

Safety and Efficacy of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification

Accuracy of Commercially Available Heart Rate Monitors in Athletes

Nutrition, Vision, and Cognition in Sport Study: Beef

Agreement and Precision Study of UNITY® DX and a Comparator Biometer

Comparison of the Beverage Hydration Index of Different Solutions

Tornier Perform™ Reversed Monopost Study

A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)

Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6

CYCLE-AD (CYcling to Cease or Limit the Effects of Alzheimer's Disease)

Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations

Fluid Balance During Exercise in the Heat With Water, Flavored Placebo, or a Carbohydrate-electrolyte Beverage Intake (The APEX Study)

Targeted Cognitive Training in Clinical High Risk (CHR) for Psychosis

Effect of Increased Enteral Protein on Body Composition of Preterm Infants

Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation Therapy

CemiplimAb Survivorship Epidemiology